Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL)

Ematologia e Centro Trapianto di Midollo, Universita di Palermo, Italy. BACKGROUND AND OBJECTIVE: Infradiaphragmatic Hodgkin's disease is rare, making up 5-12% of cases in clinical stages I and II; consequently, several questions concerning prognosis and treatment strategy remain to be answered...

Full description

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 82; no. 6; pp. 676 - 682
Main Authors Iannitto, E, Accurso, V, Federico, M, Vallisa, D, Pieresca, C, Gravina, SF, Di Costanzo, F, Di Trapani, R, Silingardi, V, Mariani, G
Format Journal Article
LanguageEnglish
Published Pavia Haematologica 01.11.1997
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ematologia e Centro Trapianto di Midollo, Universita di Palermo, Italy. BACKGROUND AND OBJECTIVE: Infradiaphragmatic Hodgkin's disease is rare, making up 5-12% of cases in clinical stages I and II; consequently, several questions concerning prognosis and treatment strategy remain to be answered. The aim of this study was to analyze the clinical and prognostic characteristics and outcome of this condition. METHODS: A series of 282 patients with CS I-II Hodgkin's disease (HD) was investigated. In 31 patients the disease was confined below the diaphragm (BDHD), and in the remaining above the diaphragm (ADHD). The presenting features and outcomes were compared in the two groups. RESULTS: The BDHD group was older (p
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0390-6078
1592-8721